Pan Cao

1.2k total citations · 1 hit paper
23 papers, 841 citations indexed

About

Pan Cao is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Pan Cao has authored 23 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Pan Cao's work include Gut microbiota and health (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and interferon and immune responses (3 papers). Pan Cao is often cited by papers focused on Gut microbiota and health (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and interferon and immune responses (3 papers). Pan Cao collaborates with scholars based in China and United States. Pan Cao's co-authors include Yongyu Chen, Wenhao Su, Weiguo Dong, Yan Chen, Na Zhan, Zuojiong Gong, Chunxia Shi, Luwen Wang, Wei‐Hua Huang and Yao Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Pan Cao

23 papers receiving 838 citations

Hit Papers

PANoptosis: A Cell Death Characterized by Pyroptosis, Apo... 2023 2026 2024 2025 2023 25 50 75 100

Peers

Pan Cao
Qiwei Ge China
George H. Rodgers United States
Yanqi Li China
Yue Zheng China
Qiwei Ge China
Pan Cao
Citations per year, relative to Pan Cao Pan Cao (= 1×) peers Qiwei Ge

Countries citing papers authored by Pan Cao

Since Specialization
Citations

This map shows the geographic impact of Pan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Cao more than expected).

Fields of papers citing papers by Pan Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Cao. The network helps show where Pan Cao may publish in the future.

Co-authorship network of co-authors of Pan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Cao. A scholar is included among the top collaborators of Pan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Cao. Pan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingqi, Qian Chen, Pan Cao, et al.. (2023). AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway. Hepatobiliary & pancreatic diseases international. 23(1). 43–51. 8 indexed citations
2.
Shi, Chunxia, Pan Cao, Yukun Wang, et al.. (2023). PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis. Journal of Inflammation Research. Volume 16. 1523–1532. 104 indexed citations breakdown →
3.
Cao, Pan, Qian Chen, Chunxia Shi, Lu-Wen Wang, & Zuojiong Gong. (2022). Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α. World Journal of Gastroenterology. 28(17). 1798–1813. 7 indexed citations
4.
Luo, Wei‐Wei, Zhen Tong, Pan Cao, et al.. (2022). Transcription-independent regulation of STING activation and innate immune responses by IRF8 in monocytes. Nature Communications. 13(1). 4822–4822. 30 indexed citations
5.
Shi, Chunxia, Maohua Pei, Yao Wang, et al.. (2022). Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine. Biochemical and Biophysical Research Communications. 594. 1–7. 29 indexed citations
6.
Cao, Pan, Qian Chen, Chunxia Shi, Luwen Wang, & Zuojiong Gong. (2022). Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway. Gut Pathogens. 14(1). 29–29. 12 indexed citations
7.
Cao, Pan, Fengjiao Wu, Dawei Xin, et al.. (2022). Multi-Omics Techniques for Soybean Molecular Breeding. International Journal of Molecular Sciences. 23(9). 4994–4994. 29 indexed citations
8.
Jiao, Fangzhou, Yao Wang, Qian Chen, et al.. (2021). Role of SIRT1 in Hepatic Encephalopathy: In Vivo and In Vitro Studies Focusing on the NLRP3 Inflammasome. Oxidative Medicine and Cellular Longevity. 2021(1). 5522708–5522708. 13 indexed citations
9.
Shi, Chunxia, Yao Wang, Fangzhou Jiao, et al.. (2021). Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation. Frontiers in Physiology. 12. 683526–683526. 8 indexed citations
10.
Cao, Pan, Qian Chen, Chunxia Shi, et al.. (2021). Pinocembrin ameliorates acute liver failure via activating the Sirt1/PPARα pathway in vitro and in vivo. European Journal of Pharmacology. 915. 174610–174610. 12 indexed citations
11.
Tian, Shan, et al.. (2021). High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 211–222. 2 indexed citations
12.
Chen, Qian, Yao Wang, Fangzhou Jiao, et al.. (2021). HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM/F‐actin signalling pathway. Journal of Cellular and Molecular Medicine. 25(15). 7218–7228. 26 indexed citations
13.
Su, Wenhao, Yongyu Chen, Pan Cao, et al.. (2020). Fusobacterium nucleatum Promotes the Development of Ulcerative Colitis by Inducing the Autophagic Cell Death of Intestinal Epithelial. Frontiers in Cellular and Infection Microbiology. 10. 594806–594806. 49 indexed citations
14.
Cao, Pan, Yongyu Chen, Xufeng Guo, et al.. (2020). Fusobacterium nucleatum Activates Endoplasmic Reticulum Stress to Promote Crohn’s Disease Development via the Upregulation of CARD3 Expression. Frontiers in Pharmacology. 11. 106–106. 36 indexed citations
15.
Liu, Yanling, Yan Chen, Wen‐Ting Fan, et al.. (2019). Mechanical Distension Induces Serotonin Release from Intestine as Revealed by Stretchable Electrochemical Sensing. Angewandte Chemie. 132(10). 4104–4110. 7 indexed citations
16.
Liu, Yanling, Yan Chen, Wen‐Ting Fan, et al.. (2019). Mechanical Distension Induces Serotonin Release from Intestine as Revealed by Stretchable Electrochemical Sensing. Angewandte Chemie International Edition. 59(10). 4075–4081. 47 indexed citations
17.
Cao, Pan, Wei‐Wei Luo, Chen Li, et al.. (2019). The heterogeneous nuclear ribonucleoprotein hnRNPM inhibits RNA virus-triggered innate immunity by antagonizing RNA sensing of RIG-I-like receptors. PLoS Pathogens. 15(8). e1007983–e1007983. 21 indexed citations
18.
Chen, Yongyu, Yan Chen, Jixiang Zhang, et al.. (2019). Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression. Theranostics. 10(1). 323–339. 149 indexed citations
19.
Chen, Zhen, Shi‐Bo Cheng, Pan Cao, et al.. (2018). Detection of exosomes by ZnO nanowires coated three-dimensional scaffold chip device. Biosensors and Bioelectronics. 122. 211–216. 117 indexed citations
20.
Luo, Wei‐Wei, Shu Li, Chen Li, et al.. (2017). iRhom2 is essential for innate immunity to RNA virus by antagonizing ER- and mitochondria-associated degradation of VISA. PLoS Pathogens. 13(11). e1006693–e1006693. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026